Navigation Links
China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call

-- Third Quarter Revenues Increase 89% to $3.51 Million versus $1.85

Million for Q3 of 2006 -- Third Quarter Net Income Before Taxes Increased 131% to $1.71 Million,

versus $0.74 Million for Q3 of 2006

NEW YORK, Nov. 21 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of organic nutritional food products, supplements, and personal care products in China, today announced that Ms. Yingxia Jiao, CEO and Chairwoman of China Yingxia, will host a conference call to discuss the Company's financial results for the third quarter ended September 30, 2007.

Net sales for the third quarter ended September 2007 totaled $3.51 million, an increase of 89% compared to $1.85 million for the third quarter of 2006. Cost of sales for the second quarter of 2007 was $0.90 million, yielding a gross profit of $2.61 million and a gross profit margin of 74%. Compared to the second quarter of 2006 cost of sales totaled $0.91 million and gross profit totaled $0.93 million yielding a gross profit of 50%.

Net income before taxes for the three months ended September 30, 2007 increased 131% to $1.71 million compared to $0.74 million for the three months ended September 30, 2007.

On the balance sheet, total assets for the third quarter of 2007 totaled $36.6 million, with reported total liabilities of $2.4 million.

''We were to pleased with the launch of our soybean product lines during the third quarter,'' stated Ms. Yingxia Jiao, CEO and Chairwoman of China Yingxia. ''We expect the soybean product line and the W3660 breed of rice aimed at diabetics and people suffering from kidney ailments to be our flagstaff products in the future quarters.''

Ms. Yingxia Jiao continued, ''I invite all our current investors and shareholders in addition to potential investors can join me on our third quarter conference call on Monday, November 26 at 9 a.m. to discuss the quarterly results in more detail and answer questions you may have.''

The conference call will take place at 9:00 a.m. Eastern, on Thursday, November 26, 2007. Anyone interested in participating should call 1-866-225- 8754 if calling within the United States, or 1-480-629-9564 if calling internationally, approximately 5 to 10 minutes prior to 9:00 a.m. There will be a playback available until December 3, 2007. To listen to the playback, please call 1-800-406-7325 if calling within the United States, or 1-303-590- 3030 if calling internationally. Please use pass code 3809920 for the replay.

This call is being webcast by ViaVid Broadcasting. The webcast may be accessed at ViaVid's Web site at .

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ("Yingxia"), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang in mainland China, and it currently has over 180 employees and 3 agricultural production bases. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, cactus-based herbal supplements, personal care products, Nestle products, and organic rice products.



SEPTEMBER 30, 2007


Current assets:

Cash and cash equivalents $ 1,501,901

Account receivables 440,448

Inventory 1,982,501

Other receivables 3,347,094

Advances to suppliers 4,254,468

Advance to affiliate 6,657,858

Loans to related party 1,432,218

Total Current Assets 19,616,487

Property and equipment, net of accumulated

depreciation of $2,996,681 16,675,349

Land use right, net 400,602

Total Assets $ 36,692,438


Current liabilities:

Accounts payable $ 1,622,516

Unearned revenue 3,337

Taxes payable 29,427

Accrued expenses and other payables 788,618

Total Current Liabilities 2,443,898

Total Liabilities 2,443,898

Stockholders' Equity

Preferred stock, $0.001 par value, 10,000,000

shares authorized; - 0 - shares outstanding

at September, 2007 --

Common stock, $0.001 par value, 100,000,000 shares

authorized; 44,333,987 shares outstanding at

September 30, 2007 44,334

Additional paid in capital 16,620,790

Accumulated other comprehensive income 1,933,256

Statutory reserves 901,463

Retained earnings 14,748,696

Total Shareholders' Equity 34,248,539

Total Liabilities and Stockholders' Equity $ 36,692,438




Nine-Month Ended Three-Month Ended

September 30, September 30,

2007 2006 2007 2006

Sales $ 10,380,713 $5,308,352 3,513,674 $1,857,392

Cost of Sales 4,003,789 2,194,473 904,605 918,481

Gross Profit 6,376,924 3,113,879 2,609,069 938,911



Research &


Expense 279,286 -- 144,547 --


general and

administrative 1,381,388 404,655 753,153 196,712


income 4,716,250 2,709,224 1,711,370 742,199

Other Income

and Expenses 2,898 (25,245) 2,412 52

Income Before

Income Taxes 4,719,148 2,683,979 1,713,782 742,251


provision for

Income Taxes -- (1,984,590) -- (2,216,535)

Net Income $4,719,148 $4,668,569 $ 1,713,782 $2,958,786

Income per

common share

Basic $ 0.13 $ 0.41 $ 0.04 $ 0.26

Diluted $ 0.13 $ 0.41 $ 0.04 $ 0.26

Weighted average

common share


Basic 35,866,849 11,418,877 40,309,204 11,418,877

Diluted 36,995,845 11,418,877 43,659,377 11,418,877

Safe Harbor Statement

The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Joe Levinson

Tel: +1-989-785-0208

SOURCE China Yingxia International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
(Date:11/28/2015)... ... 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, ... savings of up to 20% off orders $80 or more to free gifts with purchases, ... hours. , As a competitive e-commerce website for skin care and cosmetic needs, customers will ...
(Date:11/27/2015)... ... , ... According to an article published November 13th on, ... D.C. revolved around the fact that proper dental care, both at-home and in the ... between periodontal disease (more commonly referred to as gum disease) and diabetes. According to ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is a set of ... With ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Royal Philips  (NYSE: PHG, AEX: PHIA) revealed a portfolio ... Society of North America Annual Meeting (RSNA), beginning today ... Chicago . Visitors to the Philips booth ... integrated Diagnostic Imaging, Clinical Informatics, Image Guided Therapy and ... and create a superior patient experience. ...
(Date:11/27/2015)... Une nouvelle approche consistant ... contre le cancer avancé.    --> ... au traitement photodynamique au Bremachlorin contre le cancer ... nouvelle approche consistant à combiner l,immunothérapie au traitement ...    Clinical Cancer Research . ...
(Date:11/27/2015)... Nov. 26, 2015 ... of the "2016 Global Tumor Marker ... Volume and Sales Segment Forecasts, Innovative Technologies, ... report to their offering. --> ... the "2016 Global Tumor Marker Testing ...
Breaking Medicine Technology: